Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · IEX Real-Time Price · USD
3.700
-0.250 (-6.33%)
At close: Jul 19, 2024, 4:00 PM
3.630
-0.070 (-1.89%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Zentalis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for ZNTL stock have an average target of 13.14, with a low estimate of 5.00 and a high estimate of 25. The average target predicts an increase of 255.14% from the current stock price of 3.70.
Analyst Consensus: Buy
* Price targets were last updated on Jun 20, 2024.
Analyst Ratings
The average analyst rating for ZNTL stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy → Hold Downgrades $28 → $5 | Strong Buy → Hold | Downgrades | $28 → $5 | +35.14% | Jun 20, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $29 → $9 | Buy → Hold | Downgrades | $29 → $9 | +143.24% | Jun 18, 2024 |
| Stifel | Stifel | Strong Buy Maintains $32 → $10 | Strong Buy | Maintains | $32 → $10 | +170.27% | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $20 | Strong Buy | Maintains | $40 → $20 | +440.54% | Jun 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $50 → $25 | Buy | Maintains | $50 → $25 | +575.68% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
37.19M
Revenue Next Year
2.73M
from 37.19M
Decreased by -92.66%
EPS This Year
-2.80
from -4.47
EPS Next Year
-3.79
from -2.80
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 43.1M | 25.3M | 384.8M | 308.2M | 532.6M |
| Avg | 37.2M | 2.7M | 72.4M | 125.1M | 293.0M |
| Low | n/a | n/a | n/a | n/a | 50.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | -32.0% | 13,990.1% | 325.9% | 325.7% |
| Avg | - | -92.7% | 2,549.5% | 72.9% | 134.2% |
| Low | - | - | - | - | -60.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.49 | -2.90 | -2.93 | -1.63 | 0.64 |
| Avg | -2.80 | -3.79 | -3.59 | -2.26 | -0.76 |
| Low | -3.82 | -3.97 | -4.21 | -3.16 | -2.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.